HODGKIN LYMPHOMA, ADULT
Clinical trials for HODGKIN LYMPHOMA, ADULT explained in plain language.
Never miss a new study
Get alerted when new HODGKIN LYMPHOMA, ADULT trials appear
Sign up with your email to follow new studies for HODGKIN LYMPHOMA, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo may boost survival in advanced hodgkin lymphoma
Disease control Recruiting nowThis study tests whether a flat 40 mg dose of nivolumab, when added to standard chemotherapy (AVD), can help people with newly diagnosed advanced classic Hodgkin lymphoma live longer without their cancer getting worse. About 54 adults will take part. The goal is to see if this co…
Matched conditions: HODGKIN LYMPHOMA, ADULT
Phase: PHASE2 • Sponsor: National Medical Research Radiological Centre of the Ministry of Health of Russia • Aim: Disease control
Last updated May 17, 2026 05:48 UTC
-
Survivors of hodgkin lymphoma: new study probes hidden effects of past treatment
Knowledge-focused Recruiting nowThis study looks at how past treatment for Hodgkin lymphoma (chest radiation and the drug bleomycin) may affect brain blood flow and heart-lung function during exercise. Researchers will compare 100 adult survivors with healthy volunteers using non-invasive brain scans and exerci…
Matched conditions: HODGKIN LYMPHOMA, ADULT
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated May 06, 2026 16:01 UTC